Flora Growth Corp. (NASDAQ:FLGC – Get Free Report)’s share price traded up 4.8% on Monday . The company traded as high as $23.59 and last traded at $23.59. 7,510 shares changed hands during trading, a decline of 50% from the average session volume of 15,059 shares. The stock had previously closed at $22.50.
Wall Street Analysts Forecast Growth
Separately, Roth Capital set a $30.00 price objective on shares of Flora Growth and gave the company a “buy” rating in a research report on Tuesday, August 5th. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $93.00.
Get Our Latest Stock Report on Flora Growth
Flora Growth Stock Up 4.8%
Flora Growth (NASDAQ:FLGC – Get Free Report) last released its quarterly earnings results on Friday, August 1st. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.05). Flora Growth had a negative return on equity of 261.57% and a negative net margin of 24.86%.The business had revenue of $14.80 million during the quarter, compared to the consensus estimate of $11.77 million. As a group, research analysts expect that Flora Growth Corp. will post -0.93 earnings per share for the current year.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Flora Growth stock. Geode Capital Management LLC grew its holdings in Flora Growth Corp. (NASDAQ:FLGC – Free Report) by 1.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 168,572 shares of the company’s stock after acquiring an additional 3,015 shares during the period. Geode Capital Management LLC owned 29.16% of Flora Growth worth $98,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 36.01% of the company’s stock.
About Flora Growth
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.
Further Reading
- Five stocks we like better than Flora Growth
- How to Plot Fibonacci Price Inflection Levels
- 3 Big Dividend Hikes Hit the Market—1 Just Doubled Its Payout
- Why is the Ex-Dividend Date Significant to Investors?
- What NVIDIA’s Big Bet on Rival Quantinuum Means for D-Wave Stock
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Undervalued Stocks Poised to Shine in the Next Market Rally
Receive News & Ratings for Flora Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flora Growth and related companies with MarketBeat.com's FREE daily email newsletter.